The Asia Pacific vascular closure device market was valued at US$ 415.32 million in 2022 and is expected to reach US$ 731.41 million by 2030; it is estimated to record a CAGR of 7.3% from 2022 to 2030.
Based on product type, the Asia Pacific vascular closure device market is segmented into active approximators, passive approximators, and external hemostatic devices. The passive approximators segment held the largest share in 2022. The active approximators segment is further segmented into suture mediated device and staple clips mediated device. The passive approximators segment is further segmented into sealant and gel based, compression devices, and collagen plug.
By access, the Asia Pacific vascular closure device market is bifurcated into femoral access and radial access. The femoral access segment held a larger share in 2022.
By procedure, the Asia Pacific vascular closure device market is segmented into interventional cardiology, interventional radiology, and endovascular surgery. The interventional cardiology access segment held the largest share in 2022.
In terms of end user, the Asia Pacific vascular closure device market is categorized into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share in 2022.
Based on country, the Asia Pacific vascular closure device market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific vascular closure device market in 2022.
Cordis Corp, Haemonetics Corp, Abbott Laboratories, Becton Dickinson and Co, Cardinal Health Inc, Medtronic Plc, and Teleflex Inc are some of the leading companies operating in the Asia Pacific vascular closure device market.
Untapped Potential of Emerging Economies Drives Asia Pacific Vascular Closure Device Market
Emerging countries such as India and China are expected to offer significant growth opportunities for vascular closure devices market players due to rising disposable incomes, expanding patient population, increasing R&D activities, improving healthcare infrastructure, growing CVD awareness, and relatively lenient guidelines compared to developed countries. As per the World Bank, health spending in India and China increased by 3.01% and 5.35%, respectively, from 2018 to 2019. Also, there has been an upsurge in heart failure cases over the past decade in emerging markets, which has resulted in a large number of cardiovascular disease-related deaths. As per the India Brand Equity Foundation, hospitals contribute to ~70% of the revenue of the healthcare sector in India. In China, the number of private hospitals reached up to 36,000 in 2022. Moreover, the private hospitals account for ~57% of total number of hospitals in the country. The number of surgical centers and hospitals in developing markets is estimated to grow due to rising healthcare spending and a surge in the target patient population. Therefore, the development of healthcare facilities in developing economies along with a surge in a number of hospitals would propel the awareness and adoption of vascular closure devices in emerging economies. Further, vast competition in developed or matured markets encourages vascular closure device manufacturers to focus on developing markets, which is likely to offer growth opportunities for vascular closure device providers to attain a significant position in the market.Asia Pacific Vascular Closure Device Market Overview
China is a developing country with a well-established healthcare system and a large medical device industry. It is home to medical device manufacturing, pharmaceutical, and biotechnology companies operating globally. It has witnessed a significant increase in cardiovascular disease (CVD) cases due to sedentary lifestyles, unhealthy diets, and an aging population. According to a study published in BioMed Central in 2022, CVDs are responsible for more than 40% of total deaths in China. The prevalence of CVD has more than doubled during 1990-2019, with the cases rising from 50.13 million in 1990 to 120.33 million in 2019. Additionally, CVD-related mortality increased from 2.42 million in 1990 to 4.58 million in 2019. Thus, the large and flourishing medical device industry, high cardiovascular disease prevalence, and increasing demand for minimally invasive surgery propel the growth of the vascular closure devices market in China.Asia Pacific Vascular Closure Device Market Segmentation
The Asia Pacific vascular closure device market is segmented based on product type, access, procedure, end user, and country.Based on product type, the Asia Pacific vascular closure device market is segmented into active approximators, passive approximators, and external hemostatic devices. The passive approximators segment held the largest share in 2022. The active approximators segment is further segmented into suture mediated device and staple clips mediated device. The passive approximators segment is further segmented into sealant and gel based, compression devices, and collagen plug.
By access, the Asia Pacific vascular closure device market is bifurcated into femoral access and radial access. The femoral access segment held a larger share in 2022.
By procedure, the Asia Pacific vascular closure device market is segmented into interventional cardiology, interventional radiology, and endovascular surgery. The interventional cardiology access segment held the largest share in 2022.
In terms of end user, the Asia Pacific vascular closure device market is categorized into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share in 2022.
Based on country, the Asia Pacific vascular closure device market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific vascular closure device market in 2022.
Cordis Corp, Haemonetics Corp, Abbott Laboratories, Becton Dickinson and Co, Cardinal Health Inc, Medtronic Plc, and Teleflex Inc are some of the leading companies operating in the Asia Pacific vascular closure device market.
Table of Contents
1. Introduction
2. Executive Summary
3. Research Methodology
4. Asia Pacific Vascular Closure Device Market - Key Industry Dynamics
5. Vascular Closure Device Market - Asia Pacific Market Analysis
6. Asia Pacific Vascular Closure Device Market - Revenue and Forecast to 2030 - by Product Type
7. Asia Pacific Vascular Closure Device Market - Revenue and Forecast to 2030 - by Access
8. Asia Pacific Vascular Closure Device Market - Revenue and Forecast to 2030 - by Procedure
9. Asia Pacific Vascular Closure Device Market - Revenue and Forecast to 2030 - by End Users
10. Asia Pacific Vascular Closure Device Market - Country Analysis
11. Vascular Closure Device Market Industry Landscape
12. Company Profiles
13. Appendix
List of Tables
List of Figures
Companies Mentioned
- Cordis Corp
- Haemonetics Corp
- Abbott Laboratories
- Becton Dickinson and Co
- Cardinal Health Inc
- Medtronic Plc
- Teleflex Inc
